Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Tobacco | 40.5 | 30.9 | | | | | | |
| Hemp or Cannabis | 21.6 | 0.0 | | | | | | |
| Total revenues [+] | 62.1 | 30.9 | 28.1 | 25.8 | 26.4 | 16.6 | 12.3 | 8.5 |
| Products | | | | | | | | 8.5 |
| Net interest income | -0.4 | -0.1 | -0.1 | -0.1 | | | | |
| Net investment income | 0.3 | 0.3 | 1.8 | 1.1 | | | | |
| Revenue growth [+] | 100.7% | 10.1% | 8.8% | -2.2% | 59.2% | 35.2% | 44.1% | 1511.0% |
| Tobacco | 31.0% | | | | | | | |
| Hemp or Cannabis | 50155.8% | | | | | | | |
| Cost of goods sold | 60.9 | 29.5 | 26.7 | 25.8 | 25.5 | 17.3 | 12.7 | 9.1 |
| Gross profit | 1.2 | 1.5 | 1.4 | 0.0 | 0.9 | -0.7 | -0.4 | -0.6 |
| Gross margin | 1.9% | 4.8% | 5.1% | 0.1% | 3.4% | -4.3% | -3.5% | -6.8% |
| Selling, general and administrative [+] | 44.5 | 25.9 | 15.0 | 13.0 | 8.6 | 8.3 | 7.8 | 9.1 |
| Sales and marketing | | | | | | | 1.6 | 1.4 |
| General and administrative | | | | | | | 6.2 | 7.8 |
| Research and development | 6.6 | 3.9 | | | | 3.4 | 2.3 | 1.6 |
| Other operating expenses | 7.2 | 0.1 | 4.8 | 10.8 | 1.3 | 0.6 | 0.5 | -0.5 |
| EBITDA [+] | -54.2 | -27.2 | -17.9 | -23.1 | -8.3 | -12.5 | -10.6 | -10.4 |
| EBITDA growth | 99.7% | 51.6% | -22.6% | 177.8% | -33.1% | 17.0% | 2.5% | -7.6% |
| EBITDA margin | -87.3% | -87.8% | -63.7% | -89.5% | -31.5% | -75.0% | -86.7% | -121.8% |
| Depreciation | 2.2 | 0.6 | 0.4 | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 |
| EBITA | -56.4 | -27.8 | -18.3 | -23.5 | -8.7 | -12.8 | -10.9 | -10.6 |
| EBITA margin | -90.8% | -89.8% | -65.3% | -90.9% | -32.9% | -76.9% | -88.5% | -124.4% |
| Amortization of intangibles | 0.7 | 0.6 | 0.7 | 0.8 | 0.8 | 0.5 | 0.5 | 0.5 |
| EBIT [+] | -57.1 | -28.4 | -19.0 | -24.3 | -9.5 | -13.3 | -11.4 | -11.1 |
| EBIT growth | 101.0% | 49.5% | -21.8% | 155.2% | -28.4% | 16.8% | 3.0% | -5.4% |
| EBIT margin | -91.9% | -91.8% | -67.6% | -94.1% | -36.0% | -80.1% | -92.7% | -129.8% |
| Non-recurring items [+] | | | 0.2 | -0.7 | 14.5 | | | 1.0 |
| Asset impairment | | | 0.2 | 1.1 | | | | |
| Loss (gain) on sale of assets | | | | | 14.5 | | | 0.0 |
| Legal settlement | | | | -1.9 | | | | 1.0 |
| Interest income, net [+] | | | | | 1.1 | 0.1 | 0.0 | 0.0 |
| Interest expense | | | | | 0.0 | 0.0 | 0.0 | 0.1 |
| Interest income | | | | | 1.1 | 0.1 | 0.0 | 0.0 |
| Other income (expense), net [+] | -3.1 | -4.2 | -0.5 | -3.0 | 15.0 | 0.2 | -0.2 | 1.0 |
| Gain (loss) on sale of assets | | | | | | | | -0.1 |
| Realized gain (loss) on investments | -0.4 | | 0.0 | 0.2 | -0.1 | | | |
| Other | -0.3 | | | | | | | |
| Pre-tax income | -60.2 | -32.6 | -19.7 | -26.6 | -8.0 | -13.0 | -11.6 | -11.0 |
| Income taxes | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.7% | | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -59.8 | -32.6 | -19.7 | -26.6 | -8.0 | -13.0 | -11.6 | -11.0 |
| Net margin | -96.3% | -105.4% | -70.1% | -102.8% | -30.1% | -78.5% | -94.3% | -129.5% |
| |
| Basic EPS [+] | ($0.31) | ($0.21) | ($0.14) | ($0.21) | ($0.06) | ($0.13) | ($0.15) | ($0.16) |
| Growth | 48.6% | 47.0% | -32.7% | 229.2% | -50.2% | -11.2% | -10.4% | -37.7% |
| Diluted EPS [+] | ($0.31) | ($0.21) | ($0.14) | ($0.21) | ($0.06) | ($0.13) | ($0.15) | ($0.16) |
| Growth | 48.6% | 47.0% | -32.7% | 229.2% | -50.2% | -11.2% | -10.4% | -37.7% |
| |
| Shares outstanding (basic) [+] | 192.8 | 156.2 | 138.8 | 125.9 | 124.3 | 101.2 | 79.8 | 68.1 |
| Growth | 23.4% | 12.5% | 10.3% | 1.3% | 22.9% | 26.7% | 17.2% | 13.6% |
| Shares outstanding (diluted) [+] | 192.8 | 156.2 | 138.8 | 125.9 | 124.3 | 101.2 | 79.8 | 68.1 |
| Growth | 23.4% | 12.5% | 10.3% | 1.3% | 22.9% | 26.7% | 17.2% | 13.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|